HSDT - HELIUS MEDICAL TECHNOLOGIES, INC.


2.09
0.090   4.306%

Share volume: 188,754
Last Updated: 04-22-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$2.00
0.09
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
37%
Profitability 33%
Dept financing 18%
Liquidity 38%
Performance 45%
Company vs Stock growth
vs
Performance
5 Days
-1.42%
1 Month
1.46%
3 Months
-38.35%
6 Months
-70.01%
1 Year
608.47%
2 Year
-58.03%
Key data
Stock price
$2.09
P/E Ratio 
0.00
DAY RANGE
$2.04 - $2.15
EPS 
-$114.58
52 WEEK RANGE
$0.17 - $25.50
52 WEEK CHANGE
$606.08
MARKET CAP 
16.040 M
YIELD 
N/A
SHARES OUTSTANDING 
41.301 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
-1.73
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$322,532
AVERAGE 30 VOLUME 
$498,336
Company detail
CEO: Dane C. Andreeff
Region: US
Website: heliusmedical.com
Employees: 30
IPO year: 2014
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company is headquartered in Newtown, Pennsylvania.

Recent news